Colorectal cancer (CRC) is a very common disease with a high rate of mortality around the world, representing the second most frequent cause of cancer-related death. As the majority of patients are diagnosed with advanced cancer with a subsequent low five-year survival rate (10%), it is imperative to develop new strategies to treat this challenging patient population. Traditionally, patients received successive lines of chemotherapy and discontinued the treatment or switched to a different one in the event of disease progression. But despite the therapeutic advances achieved with combination chemotherapy regimens, particularly FOLFOX and FOLFIRI, considerable research has been necessary to further optimize chemotherapy for patients with metastatic colorectal cancer (mCRC). However, progress has been achieved over recent years. The most relevant relates to the approval of several new effective therapeutic drugs, such as monoclonal antibodies, which have greatly improved the outcomes for metastatic disease. The last agent approved has been panitumumab, which has been designed to target the epidermal growth factor receptor molecular pathway involved in the appearance and spread of cancer.
机构:
Univ Paris 06, Hop St Antoine, AP HP, Paris, France
GERCOR, Grp Cooperateur Multidisciplinaire Oncol, Paris, France
INSERM, CDR UMR S938, Paris, FranceUniv Paris 06, Hop St Antoine, AP HP, Paris, France
机构:
Univ Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
Univ Pisana, Unit Med Oncol, Azienda Osped, Via Roma 67, I-56126 Pisa, ItalyUniv Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
Marmorino, Federica
Boccaccino, Alessandra
论文数: 0引用数: 0
h-index: 0
机构:
Univ Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
Univ Pisana, Unit Med Oncol, Azienda Osped, Via Roma 67, I-56126 Pisa, ItalyUniv Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
Boccaccino, Alessandra
Germani, Marco Maria
论文数: 0引用数: 0
h-index: 0
机构:
Univ Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
Univ Pisana, Unit Med Oncol, Azienda Osped, Via Roma 67, I-56126 Pisa, ItalyUniv Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
Germani, Marco Maria
Falcone, Alfredo
论文数: 0引用数: 0
h-index: 0
机构:
Univ Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
Univ Pisana, Unit Med Oncol, Azienda Osped, Via Roma 67, I-56126 Pisa, ItalyUniv Pisa, Dept Translat Res & New Technol Med & Surg, Via Risorgimento 36, I-56126 Pisa, Italy
机构:
Section of Hematology/Oncology, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 2115, Chicago, 60637, ILSection of Hematology/Oncology, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 2115, Chicago, 60637, IL
Kindler H.L.
Shulman K.L.
论文数: 0引用数: 0
h-index: 0
机构:
Section of Hematology/Oncology, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 2115, Chicago, 60637, ILSection of Hematology/Oncology, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC 2115, Chicago, 60637, IL